Literature DB >> 11592820

Structure of the PCCA gene and distribution of mutations causing propionic acidemia.

E Campeau1, L R Desviat, D Leclerc, X Wu, B Pérez, M Ugarte, R A Gravel.   

Abstract

Propionyl-CoA carboxylase (PCC, EC 6.4.1.3) is a mitochondrial, biotin-dependent enzyme that functions in the catabolism of branched-chain amino acids, fatty acids with odd-numbered chain lengths, and other metabolites. It catalyzes the ATP-dependent carboxylation of propionyl-CoA to d-methylmalonyl-CoA. PCC is composed of two types of subunits, likely as alpha4beta4 or alpha6beta6, with the alpha subunit containing the covalently bound biotin prosthetic group. A genetic deficiency of PCC activity causes propionic acidemia, a potentially fatal disease with onset in severe cases in the newborn period. Affected patients may have mutations of either the PCCA or PCCB gene. In this study, we have determined the structure of the human PCCA gene which, at the present time, is only partially represented in the databases. Based on reported ESTs and confirmed by RT-PCR, we also redefine the translation initiation codon to a position 75 nucleotides upstream of the currently accepted initiation codon. We show the distribution of mutations, including three identified in this study, and renumber all reported mutations to count from the new initiation codon. The gene spans more than 360 kb and consists of 24 exons ranging from 37 to 335 bp in length. The introns range in size from 104.bp to 66 kb. We have also determined the nucleotide sequence of approximately 1 kb of the 5'-flanking region upstream of the ATG translation initiation site. The proximal 400 bp of the 5'-flanking region shows a high G + C content (67%) and is part of a putative 1-kb CpG island that extends into exon 1 and part of intron 1. The putative promoter lacks a TATA box but contains two AP-1 sites and a conservatively defined consensus GC box, the latter characteristic of the core binding sequence of the Sp1 transcription factor. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11592820     DOI: 10.1006/mgme.2001.3210

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  13 in total

1.  New splicing mutations in propionic acidemia.

Authors:  Lourdes R Desviat; Sonia Clavero; Celia Perez-Cerdá; Rosa Navarrete; Magdalena Ugarte; Belen Perez
Journal:  J Hum Genet       Date:  2006-10-19       Impact factor: 3.172

2.  Expansion of the Phenotypic Spectrum of Propionic Acidemia with Isolated Elevated Propionylcarnitine.

Authors:  Gerarda Cappuccio; Paldeep S Atwal; Taraka R Donti; Kiki Ugarte; Nadia Merchant; William J Craigen; V Reid Sutton; Sarah H Elsea
Journal:  JIMD Rep       Date:  2016-11-30

3.  Long-term sex-biased correction of circulating propionic acidemia disease markers by adeno-associated virus vectors.

Authors:  Adam J Guenzel; Renata Collard; Jan P Kraus; Dietrich Matern; Michael A Barry
Journal:  Hum Gene Ther       Date:  2015-03       Impact factor: 5.695

4.  Clinical characteristics and mutation analysis of propionic acidemia in Thailand.

Authors:  Nithiwat Vatanavicharn; Somporn Liammongkolkul; Osamu Sakamoto; Mahattana Kamolsilp; Achara Sathienkijkanchai; Pornswan Wasant
Journal:  World J Pediatr       Date:  2014-01-25       Impact factor: 2.764

Review 5.  Methylmalonic and propionic acidemias: clinical management update.

Authors:  Jamie L Fraser; Charles P Venditti
Journal:  Curr Opin Pediatr       Date:  2016-12       Impact factor: 2.856

6.  Qualitative and quantitative analysis of the effect of splicing mutations in propionic acidemia underlying non-severe phenotypes.

Authors:  Sonia Clavero; Belén Pérez; Ana Rincón; Magdalena Ugarte; Lourdes R Desviat
Journal:  Hum Genet       Date:  2004-07-02       Impact factor: 4.132

7.  Short-term rescue of neonatal lethality in a mouse model of propionic acidemia by gene therapy.

Authors:  Sean E Hofherr; Julien S Senac; Christopher Y Chen; Donna J Palmer; Philip Ng; Michael A Barry
Journal:  Hum Gene Ther       Date:  2009-02       Impact factor: 5.695

8.  A novel PCCB mutation in a Thai patient with propionic acidemia identified by exome sequencing.

Authors:  Thantrira Porntaveetus; Chalurmpon Srichomthong; Kanya Suphapeetiporn; Vorasuk Shotelersuk
Journal:  Hum Genome Var       Date:  2015-09-17

Review 9.  Pushing the limits of the scanning mechanism for initiation of translation.

Authors:  Marilyn Kozak
Journal:  Gene       Date:  2002-10-16       Impact factor: 3.688

10.  A Novel PCCA Mutation in a Patient With Late-Onset Propionic Acidemia Identified by Genetic Diagnosis Panel.

Authors:  Yanyun Wang; Yun Sun; Tao Jiang
Journal:  Front Pediatr       Date:  2018-08-21       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.